An in-vitro method for screening accessible biological markers in pathologic tissues and biological marker for detecting breast cancer

摘要

The present invention refers to a biological marker for breast cancer selected from the group consisting of Annexin A6, Myoferlin, Thy-1 membrane glycoprotein precursor, EMILIN-1 precursor, Voltage-dependent anion-selective channel protein 3 and their use in detection of breast cancer and as medicament.